Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Asset Utilization Ratio: 2021-2023

Historic Asset Utilization Ratio for Candel Therapeutics (CADL) over the last 2 years, with Sep 2023 value amounting to -0.03.

  • Candel Therapeutics' Asset Utilization Ratio fell 2599.97% to -0.03 in Q3 2023 from the same period last year, while for Sep 2023 it was -0.03, marking a year-over-year decrease of 2599.97%. This contributed to the annual value of 0.00 for FY2022, which is 23.61% down from last year.
  • According to the latest figures from Q3 2023, Candel Therapeutics' Asset Utilization Ratio is -0.03, which was down 83.85% from -0.02 recorded in Q2 2023.
  • Candel Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.00 during Q3 2021, with a 5-year trough of -0.03 in Q3 2023.
  • Its 3-year average for Asset Utilization Ratio is -0.01, with a median of 0.00 in 2022.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first grew by 13.81% in 2022, then tumbled by 2,599.97% in 2023.
  • Over the past 3 years, Candel Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.00 in 2021, then grew by 13.81% to 0.00 in 2022, then slumped by 2,599.97% to -0.03 in 2023.
  • Its last three reported values are -0.03 in Q3 2023, -0.02 for Q2 2023, and -0.01 during Q1 2023.